Amgen price target lowered to $330 from $360 at RBC Capital
RBC Capital analyst Gregory Renza lowered the firm’s price target on Amgen (AMGN) to $330 from $360 and keeps an Outperform rating on the ...
USA Today10h
'The American people are angry and want change': Bernie Sanders slams Democrats for loss
Sen. Bernie Sanders is blaming the Democratic Party after Vice President Kamala Harris lost to now President-elect Donald Trump and Republicans gained control of the Senate. In a statement shared ...
Amgen Drug Delivers More Weight Loss Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
Law Talk: Compounded Weight-Loss Drugs
In this edition of Law Talk, Attorney Megan Collins discusses the growing market for compounded weight-loss drugs and how you can stay safe when selecting certain medicines.
Amgen's Phase 2 Results Were Not Bad, Don't Let Mr. Market Fool You
Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.
The Globe and Mail12h
Stocks Slip Before the Open With Focus on Key U.S. Inflation Data and Trump’s Picks
December S&P 500 E-Mini futures (ESZ24) are down -0.18%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.33% this morning as investors digested Donald Trump’s latest cabinet appointments ...
BioSpace14h
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...
kffhealthnews14h
Patients Lose 20% Of Weight With New Once-A-Month Shot MariTide
A new experimental weight loss drug from Amgen — the first in a growing group of drugs aimed at once-a-month injections instead of once a week — helped patients lose up to 20% of their weight in one ...
Jordan Says Lebanon Ceasefire Step To Ending Gaza War
Jordan welcomed a ceasefire that entered into force Wednesday between Israel and Hezbollah in Lebanon, calling it a critical step towards ending the war between Israel and Hamas in Gaza.
Last Asylum Seekers Leave Controversial UK Barge
The last remaining asylum seekers being housed on the controversial floating accommodation barge Bibby Stockholm in southern England have left, local authorities said on Wednesday.
Amgen’s Stock Outlook: Balancing Maritide’s Weight Loss Data Concerns and Diabetes Treatment Potential
Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Amgen (AMGN – Research Report), retaining the price target of $335.00.Don't ...
Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms
Amgen Inc.’s stock closed down 4.8% Tuesday, after the company said a mid-stage trial of its weight-loss treatment MariTide showed up to 20% average weight loss at 52 weeks. Analysts were expecting ...